Reset

Advanced Filters
11:15am - 12:30pm EDT - March 20, 2021

Saturday


Objectives:
  • Recognize the role of advance practice providers (APPs) in oncology care and how to effectively utilize them in standard practice.
  • Review useful strategies centers have developed to recruit and retain APPs at their institutions.
Saturday


Objectives:
  • Identify clinical challenges in managing patients with a variety of cancers.
  • Develop an evidence-based approach for the management of these patients.
Saturday


Objectives:
  • Review the results of oncology research as presented in the five top-rated posters.
03:30pm - 05:00pm EDT - March 20, 2021

Saturday
03:30pm - 04:15pm EDT - March 20, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Review the recommended actionable oncogenic biomarkers for eligible patients with metastatic non-small cell lung cancer (NSCLC).
  • Identify the recommended immune biomarkers for eligible patients with metastatic NSCLC.
  • Describe the need for biomarker testing for eligible patients with metastatic NSCLC.
Saturday
03:30pm - 04:15pm EDT - March 20, 2021
Track: Clinical Updates in Oncology


Objectives:
  • List the patient and case-specific factors that should inform first-line treatment of melanoma brain metastases.
  • Identify multidisciplinary team members needed and patient/case characteristics that should inform treatment selection in patients with melanoma brain metastases.
  • Describe approaches for managing symptoms and quality of life issues for patients with melanoma brain metastases.
Saturday


Objectives:
  • Describe the current role of primary care physicians (PCPs) in cancer care.
  • Explain the importance of having PCPs as part of the oncology care team.
  • Identify ways to increase PCP involvement in cancer care.
Saturday
04:15pm - 05:00pm EDT - March 20, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Review the specific appropriate targeted therapy for patients with metastatic non-small cell lung cancer (NSCLC) who have certain actionable oncogenic biomarkers.
  • Describe the appropriate immunotherapy regimens for patients with metastatic NSCLC who are not eligible for targeted therapies.
  • Select the optimal treatment for their patients with metastatic NSCLC.
Saturday
04:15pm - 05:00pm EDT - March 20, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Describe clinical contexts in which molecular testing may be useful for management of cutaneous melanoma.
  • Explain the challenges to using and interpreting molecular testing for diagnostic or prognostic purposes.
  • Review molecular testing options for patients with stage III or stage IV disease, what material should be used for testing, and how results may inform treatment decisions.